Evidence map›Paper›PMID 18513163›Full record

ArticleStem cells and development2008

Dlk1 influences differentiation and function of B lymphocytes.

Ramadevi Raghunandan, Maria Ruiz-Hidalgo, Yifeng Jia, Rachael Ettinger, Eva Rudikoff, Patrick Riggins, Richard Farnsworth, Abeba Tesfaye, Jorge Laborda, Steven R Bauer

Abstract read
In one paragraph

Article in Stem cells and development, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Science advances · 2023
    Article
  5. ImprintedeLife · 2023
    Article
  6. Article
  7. Review
  8. Functional Identification of PorcineAnimals : an open access journal from MDPI · 2022
    Article
  9. Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Review
  10. Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  11. Imprinted Genes and Multiple Sclerosis: What Do We Know?International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ramadevi RaghunandanCellular and Tissue Therapies Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA.
Maria Ruiz-Hidalgo
Yifeng Jia
Rachael Ettinger
Eva Rudikoff
Patrick Riggins
Richard Farnsworth
Abeba Tesfaye
Jorge Laborda
Steven R Bauer
Center for Biologics Evaluation and Research · USUniversity of Castilla-La Mancha · ESNational Institute of Arthritis and Musculoskeletal and Skin Diseases · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

The Dlk1 (delta-like-1) gene is a member of the epidermal growth factor (EGF)-like homeotic gene family. It influences cell-cell interactions between stromal cells and pro-B cells in vitro. To define the in vivo role of the dlk protein in B cell development, we established a Dlk1-/- mouse model. In spleens of Dlk1-/- mice, transitional B cell numbers were increased and the ratio between transitional B cell subsets was altered. Numbers of follicular B cells decreased, while the number of marginal zone B cells and the size of the marginal zone were increased. Loss of dlk resulted in increased immunoglobulin G1 (IgG1) and IgG3 in preimmune sera. Furthermore, there was an exaggerated primary T-dependent antigen-specific humoral immune response. In bone marrow, the lack of dlk led to increased numbers of the earliest B lineage cells in young mice without affecting numbers of later B lineage cells. In vitro experiments showed that lack of dlk on either stromal cells or pro-B cells caused changes in differentiation and proliferation of pro-B cells, suggesting that lack of dlk leads to changes in cell-cell interactions in the bone marrow microenvironment. These results show that dlk expression is essential for normal B cell development.

Indexed as

Cell DifferentiationAnimalsAntibody FormationB-LymphocytesBone Marrow CellsCalcium-Binding ProteinsCell LineageGene TargetingHomeostasisImmunoglobulinsIntercellular Signaling Peptides and ProteinsLymphocyte SubsetsMiceSpleenStem CellsT-LymphocytesCalcium-Binding ProteinsDlk1 protein, mouseImmunoglobulinsIntercellular Signaling Peptides and Proteins

Identifiers

PMID18513163
PMCPMC3189718
OpenAlexW2018289634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.